Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Alp, Keziban Merve (1) Birchmeier, Walter Prof. Dr. (7) Blankenstein, Thomas Prof. Dr. (2) Blüthgen, Nils (1) Dahlmann, Mathias Dr. (29) Daniel, Peter Prof. Dr. (3) Fritsche, Raphaela Dr. (2) Haas, Simon Dr. rer. nat. (1) Hartl, Kimberly (1) Herse, Florian PD Dr. (1) Holz, Maximilian (1) Horne, Arik (1) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (2) Izsvak, Zsuzsanna Dr. (2) Janke, Jürgen Dr. (1) Janz, Martin Dr. (1) Keller, Ulrich Dr. med. (2) Kobelt, Dennis Dr. (51) Koch, Gudrun (1) Leutz, Achim Prof. Dr. (2) Malchin, Victoria (1) Na, Il-Kang Dr. (1) Nazare, Marc (1) Nguyen, Tam Hoai Dr. (1) Nimptsch, Katharina Dr. (1) Özerdem, Ceren (1) Pischon, Tobias Prof. Dr. (1) Popp, Oliver Dr. (3) Rathjen, Fritz Prof. Dr. (1) Rehm, Armin Dr. (1) Röefzaad, Claudia (1) Schlag, Peter M. Prof. Dr. (378) Schmitt, Clemens Prof. Dr. (2) Schöpe, Paul Curtis (2) Schroeder, Leif Dr. (1) Simon, Mareike Dr. (1) Smith, Janice (16) Solé Boldo, Llorenc Dr. rer. nat. (1) Specker, Edgar Dr. (2) Sperling, Silke Prof. Dr. (1) Sporbert, Anje Dr. (1) Stein, Ulrike Prof. Dr. (187) Torke, Sebastian Dr. (4) Uckert, Wolfgang Prof. Dr. (1) Veltsista, Paraskevi Danai (1) von Kries, Jens Peter Dr. (2) Walther, Wolfgang Prof. Dr. (145) Willimsky, Gerald Dr. (1) Willnow, Thomas Prof. Dr. (1) Wolf, Jana Prof. Dr. (1) Zimmermann, Karin Dr. (1) (-) Mertins, Philipp Dr. (4) (-) Pezzutto, Antonio Prof. Dr. (4) (-) Wenzel, Katrin Dr. (1) Advanced Light Microscopy (1) AG Müller/Dechend (ECRC) (10) AG Schreiber [ECRC] (1) Animal Phenotyping (2) Ankerproteine und Signaltransduktion (1) Bioinformatics and Omics Data Science (1) Bioinformatik der Genregulation (2) Biologie maligner Lymphome (3) Electron Microscopy (2) Endokrinologie, Diabetes und Stoffwechselmedizin (1) Entwicklung Mechanismus-basierter Krebstherapien (10) Entwicklungsneurobiologie (1) Epigenetische Modifikationen in Neuroblastom (1) Experimentelle Ultrahochfeld-MR (1) Flow Cytometry (1) Genetik und Genomik von Herz- Kreislauferkrankungen (14) Genetik von Angeborenen Herzerkrankungen (1) Genom-Editierung & Krankheitsmodelle (2) Genomdiversifikation & Integrität (2) Hochschulambulanz für Neuroimmunologie (1) Hypertonie-vermittelter Endorganschaden (10) Hypertonie bedingte Endorganschäden (10) Immundysregulationen in der Onkologie (1) Immunregulation und Krebs (2) Intrazelluläre Proteolyse (1) Magnetic Resonance (1) Mathematische Modellierung zellulärer Prozesse (1) Mathematische Zellphysiologie (2) Mikroumgebung als Regulator bei Autoimmunität und Krebs (1) Mobile DNA (1) Molekularbiologie von Hormonen im Herz-Kreislaufssystem (1) Molekulare Herz- Kreislaufforschung (2) Molekulare Immunologie und Gentherapie (20) Molekulare Onkologie (1) Myologie (7) Nephrologie und entzündliche Gefäßerkrankungen (1) Nicht-Kodierende RNAs und Mechanismen der Genregulation im Cytoplasma (1) Pluripotent Stem Cells (1) Proteom Dynamik (3) Proteomics (115) Proteomics and Metabolomics (1) Psychoneuroimmunologie (5) RNA Biologie und Posttranscriptionale Regulation (5) Synaptische Transmission und Plastitzität (1) Systembiologie von Gen-regulatorischen Elementen (2) Transgenics (2) Translational Bioinformatics (8) Translationale Kardiologie und Funktionelle Genomforschung (4) (-) Translationale Onkologie solider Tumore (9) Tumorgenetik und zelluläre Stressantworten (1) Tumorheterogenität und Therapieresistenz in pädiatrischen Tumoren (1) Zelluläre Neurowissenschaften (7) 2005 (1) 2007 (1) 2012 (2) 2021 (3) 2022 (2) 9 Ergebnisse: Active Filter: Mertins, Philipp Dr.Pezzutto, Antonio Prof. Dr.Wenzel, Katrin Dr.Translationale Onkologie solider Tumore Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Mai 2007 / Biol Chem Expression of the protein phosphatase 1 inhibitor KEPI is downregulated in breast cancer cell lines and tissues and involved in the regulation of the tumor suppressor EGR1 via the MEK-ERK pathway K. Wenzel K. Daskalow F. Herse S. Seitz U. Zacharias J.A. Schenk H. Schulz N. Huebner B. Micheel P.M. Schlag K.J. Osterziel C. Ozcelik S. Scherneck B. Jandrig 01. Dezember 2012 / OncoImmunology HER2/neu DNA vaccination by intradermal gene delivery in a mouse tumor model: gene gun is superior to jet injector in inducing CTL responses and protective immunity T. Nguyen-Hoai D. Kobelt O. Hohn M.D. Vu P.M. Schlag B. Doerken S. Norley M. Lipp W. Walther A. Pezzutto J. Westermann 30. April 2012 / Immunol Lett Detection of circulating tumor-associated antigen depends on the domains recognized by the monoclonal antibodies used: N-terminal trimmed EpCAM-levels are much higher than untrimmed forms O. Schmetzer G. Moldenhauer A. Nicolaou P. Schlag R. Riesenberg A. Pezzutto 01. Januar 2005 / J Immunol Quality of recombinant protein determines the amount of autoreactivity detected against the tumor-associated epithelial cell adhesion molecule antigen: low frequency of antibodies against the natural protein O. Schmetzer G. Moldenhauer R. Riesenberg J.R. Pires P.M. Schlag A. Pezzutto 26. August 2021 / Oncogene The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis D. Kobelt D. Perez-Hernandez C. Fleuter M. Dahlmann F. Zincke J. Smith R. Migotti O. Popp S. Burock W. Walther G. Dittmar P. Mertins U. Stein 21. Oktober 2021 / Mol Cancer Peritoneal metastasis of colorectal cancer (pmCRC): identification of predictive molecular signatures by a novel preclinical platform of matching pmCRC PDX/PD3D models M. Dahlmann G. Gambara B. Brzezicha O. Popp E. Pachmayr L. Wedeken A. Pflaume M. Mokritzkij S. Gül-Klein A. Brandl C. Schweiger-Eisbacher P. Mertins J. Hoffmann U. Keilholz W. Walther C. Regenbrecht B. Rau U. Stein 01. Januar 2021 / Neoplasia Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine M. Rivera I. Fichtner A. Wulf-Goldenberg C. Sers J. Merk G. Patone K.M. Alp T. Kanashova P. Mertins J. Hoffmann U. Stein W. Walther 23. Februar 2022 / Nat Commun Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma Y.L.D. Ng E. Ramberger S.R. Bohl A. Dolnik C. Steinebach T. Conrad S. Müller O. Popp M. Kull M. Haji M. Gütschow H. Döhner W. Walther U. Keller L. Bullinger P. Mertins J. Krönke 23. Juni 2022 / Methods Mol Biol Gene gun Her2/neu DNA vaccination: evaluation of vaccine efficacy in a syngeneic Her2/neu mouse tumor model T. Nguyen-Hoai O. Hohn A. Pezzutto J. Westermann
01. Mai 2007 / Biol Chem Expression of the protein phosphatase 1 inhibitor KEPI is downregulated in breast cancer cell lines and tissues and involved in the regulation of the tumor suppressor EGR1 via the MEK-ERK pathway K. Wenzel K. Daskalow F. Herse S. Seitz U. Zacharias J.A. Schenk H. Schulz N. Huebner B. Micheel P.M. Schlag K.J. Osterziel C. Ozcelik S. Scherneck B. Jandrig
01. Dezember 2012 / OncoImmunology HER2/neu DNA vaccination by intradermal gene delivery in a mouse tumor model: gene gun is superior to jet injector in inducing CTL responses and protective immunity T. Nguyen-Hoai D. Kobelt O. Hohn M.D. Vu P.M. Schlag B. Doerken S. Norley M. Lipp W. Walther A. Pezzutto J. Westermann
30. April 2012 / Immunol Lett Detection of circulating tumor-associated antigen depends on the domains recognized by the monoclonal antibodies used: N-terminal trimmed EpCAM-levels are much higher than untrimmed forms O. Schmetzer G. Moldenhauer A. Nicolaou P. Schlag R. Riesenberg A. Pezzutto
01. Januar 2005 / J Immunol Quality of recombinant protein determines the amount of autoreactivity detected against the tumor-associated epithelial cell adhesion molecule antigen: low frequency of antibodies against the natural protein O. Schmetzer G. Moldenhauer R. Riesenberg J.R. Pires P.M. Schlag A. Pezzutto
26. August 2021 / Oncogene The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis D. Kobelt D. Perez-Hernandez C. Fleuter M. Dahlmann F. Zincke J. Smith R. Migotti O. Popp S. Burock W. Walther G. Dittmar P. Mertins U. Stein
21. Oktober 2021 / Mol Cancer Peritoneal metastasis of colorectal cancer (pmCRC): identification of predictive molecular signatures by a novel preclinical platform of matching pmCRC PDX/PD3D models M. Dahlmann G. Gambara B. Brzezicha O. Popp E. Pachmayr L. Wedeken A. Pflaume M. Mokritzkij S. Gül-Klein A. Brandl C. Schweiger-Eisbacher P. Mertins J. Hoffmann U. Keilholz W. Walther C. Regenbrecht B. Rau U. Stein
01. Januar 2021 / Neoplasia Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine M. Rivera I. Fichtner A. Wulf-Goldenberg C. Sers J. Merk G. Patone K.M. Alp T. Kanashova P. Mertins J. Hoffmann U. Stein W. Walther
23. Februar 2022 / Nat Commun Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma Y.L.D. Ng E. Ramberger S.R. Bohl A. Dolnik C. Steinebach T. Conrad S. Müller O. Popp M. Kull M. Haji M. Gütschow H. Döhner W. Walther U. Keller L. Bullinger P. Mertins J. Krönke
23. Juni 2022 / Methods Mol Biol Gene gun Her2/neu DNA vaccination: evaluation of vaccine efficacy in a syngeneic Her2/neu mouse tumor model T. Nguyen-Hoai O. Hohn A. Pezzutto J. Westermann